<p>The Spearman’s rank correlation coefficient (rho) and the <i>p-</i>value are shown in each plot. The number of isolates from PI-experienced individuals were 717, 103, 4,107, and 9,985 for SSA, SSEA, Latin America/Caribbean, and the pooled upper-income countries (UIC; Europe, North America, and upper-income Asian countries), respectively.</p
OBJECTIVES: To monitor HIV-1 transmitted drug resistance (TDR) in a well defined urban area with lar...
Background: The emergence and transmission of HIV-1 drug resistance (HIVDR) has raised concerns afte...
<p>SSA, sub-Saharan Africa; CSA, Central and South America; PI, protease inhibitors; NRTI, nucleosid...
<p>The Spearman’s rank correlation coefficient (rho) and the <i>p-</i>value are shown in each plot. ...
<p>Absolute and cumulative prevalence of each major nucleoside (NRTI) and nonnucleoside RT Inhibitor...
Regional and subtype-specific mutational patterns of HIV-1 transmitted drug resistance (TDR) are ess...
<p>Data are median (IQR) of study-level prevalence of individuals with any (overall) and NRTI-, NNRT...
Background Regional and subtype-specific mutational patterns of HIV-1 transmitted drug resistance (T...
BACKGROUND: Transmitted drug resistance (TDR) is critical to managing HIV-1-infected individuals and...
The emergence and transmission of HIV-1 drug resistance (HIVDR) has raised concerns after rapid glob...
<p>Drug resistance mutation frequency is shown for the studies included in the meta-analysis. Only s...
<p>Drug resistance mutation frequency is shown for the studies included in the meta-analysis. Only s...
HIV Gag mutations have been reported to confer PI drug resistance. However, clinical implications ar...
BACKGROUND:The emergence and transmission of HIV-1 drug resistance (HIVDR) has raised concerns after...
BACKGROUND: In Europe, a continuous programme (SPREAD) has been in place for ten years to study tran...
OBJECTIVES: To monitor HIV-1 transmitted drug resistance (TDR) in a well defined urban area with lar...
Background: The emergence and transmission of HIV-1 drug resistance (HIVDR) has raised concerns afte...
<p>SSA, sub-Saharan Africa; CSA, Central and South America; PI, protease inhibitors; NRTI, nucleosid...
<p>The Spearman’s rank correlation coefficient (rho) and the <i>p-</i>value are shown in each plot. ...
<p>Absolute and cumulative prevalence of each major nucleoside (NRTI) and nonnucleoside RT Inhibitor...
Regional and subtype-specific mutational patterns of HIV-1 transmitted drug resistance (TDR) are ess...
<p>Data are median (IQR) of study-level prevalence of individuals with any (overall) and NRTI-, NNRT...
Background Regional and subtype-specific mutational patterns of HIV-1 transmitted drug resistance (T...
BACKGROUND: Transmitted drug resistance (TDR) is critical to managing HIV-1-infected individuals and...
The emergence and transmission of HIV-1 drug resistance (HIVDR) has raised concerns after rapid glob...
<p>Drug resistance mutation frequency is shown for the studies included in the meta-analysis. Only s...
<p>Drug resistance mutation frequency is shown for the studies included in the meta-analysis. Only s...
HIV Gag mutations have been reported to confer PI drug resistance. However, clinical implications ar...
BACKGROUND:The emergence and transmission of HIV-1 drug resistance (HIVDR) has raised concerns after...
BACKGROUND: In Europe, a continuous programme (SPREAD) has been in place for ten years to study tran...
OBJECTIVES: To monitor HIV-1 transmitted drug resistance (TDR) in a well defined urban area with lar...
Background: The emergence and transmission of HIV-1 drug resistance (HIVDR) has raised concerns afte...
<p>SSA, sub-Saharan Africa; CSA, Central and South America; PI, protease inhibitors; NRTI, nucleosid...